Form 4: SPRB CFO Gharib Vests 2,053 Performance RSUs

Spruce Biosciences' President and CFO, Samir M. Gharib, vested 2,053 performance-based Restricted Stock Units after the Board certified performance goals were met, resulting in a net issuance of 1,392 shares.

Summary

• Samir M. Gharib, President and CFO of Spruce Biosciences, Inc. (SPRB), vested 2,053 performance-based Restricted Stock Units (RSUs).
• The vesting occurred on October 20, 2025, after the Issuer's Board of Directors certified that specified performance goals were met.
• Following the vesting, 661 shares were withheld to cover tax liabilities at a price of $148.16 per share.
• This resulted in a net issuance of 1,392 shares of common stock to Mr. Gharib.
• Mr. Gharib now directly beneficially owns 6,066 shares of common stock.

Sentiment

Score: 7

Explanation: The vesting of performance-based RSUs indicates that the company's management has met specific internal performance goals, which is generally a positive sign for operational execution. The transaction itself is routine for executive compensation.

Positives

• The company's Board of Directors certified that specified performance goals were met, leading to the vesting of performance-based RSUs.
• The vesting of performance-based RSUs indicates successful achievement of internal targets by management, aligning executive incentives with company performance.

Negatives

• 661 shares were withheld for taxes, which is a standard practice for RSU vesting but reduces the immediate net share acquisition by the executive.

Industry Context

This filing represents a routine insider transaction related to executive compensation, specifically the vesting of performance-based Restricted Stock Units. Such transactions are common across all industries, particularly in biotechnology where executive incentives are often tied to achieving specific milestones or performance targets.

Stakeholder Impact

• Shareholders: The vesting and net issuance of shares to a key executive aligns executive incentives with shareholder value creation, as performance goals were met. The withholding of shares for taxes is a standard practice and does not represent a dilution event beyond the initial grant.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event where performance-based Restricted Stock Units vested due to the achievement of specified goals. While the meeting of performance goals is a positive indicator of management execution, this specific transaction does not provide new material information that would warrant a change in investment thesis. It confirms expected compensation practices and successful internal goal attainment, supporting a 'hold' recommendation for existing investors.

Keywords

Spruce Biosciences, SPRB, Samir Gharib, Form 4, SEC Filing, Restricted Stock Units, RSU Vesting, Insider Transaction, Executive Compensation, Performance Goals